SCHEMBL6898392

SCHEMBL6898392

COC(=O)c1cccc2c1c1c(O)cc(C)cc1n2Cc1ccccc1F

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.44
LMNA P02545 2/20 0.44
ALDH1A1 P00352 4/20 0.43
KDM4E B2RXH2 3/20 0.43
KMT2A Q03164 3/20 0.41
MEN1 O00255 2/20 0.41
POLB P06746 2/20 0.39
THRB P10828 1/20 0.39
NPC1 O15118 2/20 0.39
MAPK1 P28482 2/20 0.39
TSHR P16473 1/20 0.39
GAA P10253 1/20 0.39
ALOX15 P16050 1/20 0.39
RORC P51449 1/20 0.39
HSP90AA1 P07900 1/20 0.38
HSP90B1 P14625 1/20 0.38
P2RX7 Q99572 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
ECE1 P42892 1/20 0.38
PSMD14 O00487 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6892544 0.89 MAPT (0.44) L3MBTL1LMNAALDH1A1KDM4EKMT2A
SCHEMBL6691803 0.89 LMNA (0.47) L3MBTL1LMNAALDH1A1KDM4EKMT2A
SCHEMBL6892764 0.89 LMNA (0.44) L3MBTL1LMNAALDH1A1KDM4EKMT2A
SCHEMBL6894204 0.89 L3MBTL1 (0.44) L3MBTL1LMNAALDH1A1KDM4EKMT2A
SCHEMBL6775481 0.88 ALDH1A1 (0.44) L3MBTL1LMNAALDH1A1KDM4EKMT2A
SCHEMBL6894986 0.88 HSP90AA1 (0.38) L3MBTL1LMNAALDH1A1KDM4EKMT2A
SCHEMBL6897295 0.88 MAPT (0.48) L3MBTL1LMNAALDH1A1KDM4EKMT2A
SCHEMBL6898407 0.87 YWHAH (0.43) L3MBTL1LMNAALDH1A1KDM4EKMT2A
SCHEMBL6896006 0.87 RORC (0.42) KDM4EKMT2AMEN1RORCHSP90AA1
SCHEMBL6896629 0.87 MAPK8 (0.47) L3MBTL1ALDH1A1KDM4EKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6713645-B1 INHIBITING SPLA2 MEDIATED RELEASE OF FATTY ACIDS FOR TREATMENT OF CONDITIONS SUCH AS SEPTIC SHOCK ELI LILLY AND COMPANY 2004-03-30 US disclosed
US-6177440-B1 THERAPY FOR SEPSIS SHOCK; PHOSPHOLIPASE INHBITOR ELI LILLY AND COMPANY 2001-01-23 US disclosed
EP-0952149-A2 Substituted carbazoles, process for their preparation and their use as sPLA2 inhibitiors ELI LILLY AND COMPANY (US) 1999-10-27 EP disclosed